Literature DB >> 10372304

[Ambulatory cardiac phase II rehabilitation--"the Cologne model"--including 3-year-outcome after termination of rehabilitation].

B Bjarnason-Wehrens1, H G Predel, C Graf, R Rost.   

Abstract

From January 1992 until December 1994 the Cologne model of ambulant cardiac rehabilitation (ACR) in the greater area of Cologne, Germany, was performed and is still in progress. In Germany until 1992 the cardiac rehabilitation was exclusively performed stationary. The objective of the "Cologne model" was to evaluate, whether the transfer of the stationary cardiac rehabilitation programs into the ambulatory setting is achievable without deficits in efficiency, safety and overall quality. The results obtained are intended to serve for standardization and quality control of future ambulatory cardiac rehabilitation programs in Germany. From 1992 to 1994 108 patients (94 men, 14 women; 52.3 +/- 8.0 years old) with coronary artery disease (CAD) which were compatible with the criteria of the "Cologne model" (Table 1) participated in the 4-week ACR. The indications for inclusion into the ACR were in 74 cases a myocardial infarction (MI), in 34 cases CAD without MI, but with PTCA/stent-procedure (Table 3). Seven patients discontinued the ACR prematurely, 2 patients because of cardiovascular reasons. Reasons for the preference of the ambulatory over a stationary cardiac rehabilitation program were in 40.6% of the patients refusal of "hospital ambience", in 43.6% familiar or in 12.9% professional reasons. During the 4-week ACR patients participated in a mean of 72.9 +/- 6.7 hours of therapy (Table 4). As a result of the ACR exercise tolerance increased highly significantly (**) from 116.4 +/- 28.8 to 129.9 +/- 34.6 watt). This improvement was maintained at the 1- and 3-year control (128.7 +/- 35.8**) examinations (Tables 5 and 7). One year after ACR 77% of the patients stated to be physically active in ambulatory heart groups (AHG) (27.6%) or on their own (49.4%). Three years after ACR the rate of regularly physically active patients still was 59.2%. Furthermore, as a result of ACR the dietary behavior was changed significantly. There was a reduction in the consumption of lipids by 20.8%, saturated fatty acids by 30.7% and of cholesterol by 30.5%. The plasma concentrations of cholesterol decreased from 231 +/- 49.8 to 213.2 +/- 35.9 mg%**. Six (and 12) months after ACR they increased again to 225.6 +/- 39.4 mg%. Three years after ACR the mean cholesterol level was 219.1 +/- 39.3 mg%. In the high risk group (cholesterol at the initial visit > 220 mg%) cholesterol levels were reduced from 266 +/- 44 to 232 +/- 31.9 mg%**. Six and 12 months after ACR they were 239.7 +/- 35.8 mg% and 245.8 +/- 32.6 mg%, respectively, (Tables 6 and 7) and still significantly lower than before ACR, though only 19% of the patients were treated with lipid lowering agents. Three years after ACR cholesterol were 234.6 +/- 37.7 mg%** in the high-risk group. 34.2% of the patients received lipid lowering agents. Mean body weight remained unaltered over the 3-year period. Smoking behavior was not altered significantly during the 4-week ACR. However, before the cardiovascular event 67.3% of the patients had smoked cigarettes. At the beginning and at the end of ACR 20.8% of the patients still smoked. During the ACR the number of smoked cigarettes was reduced significantly from 32.4 +/- 15.2 to 6.9 +/- 5.2 cigarettes per day. One year after ACR 23% of the patients were smokers, 3 years after ACR the percentage of smokers increased to 30.3%. Before ACR 73.3% of the patients were still working. During the first 6 months after ACR 68.2% returned to work and the percentage increased to 73% in the following 6 months. The results demonstrate that it is achievable to transfer the contents of the established stationary cardiac rehabilitation programs into the ambulatory setting without loss of efficiency, safety and overall quality. It is further confirmed, that it is necessary to continuously evaluate the results of the cardiac rehabilitation program on a long-term basis. (ABSTRACT TRUNCATED)

Entities:  

Mesh:

Year:  1999        PMID: 10372304     DOI: 10.1007/bf03042127

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  46 in total

Review 1.  [Optimizing the lipid profile in secondary and primary prevention--is there still doubt after 4S, WOS and CARE?].

Authors:  H Roskamm
Journal:  Z Kardiol       Date:  1996-12

2.  [Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region].

Authors:  A Enbergs; A Liese; M Heimbach; S Kerber; H H Scheld; G Breithardt; P Kleine-Katthöfer; U Keil
Journal:  Z Kardiol       Date:  1997-04

3.  Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.

Authors:  J B Cavender; W J Rogers; L D Fisher; B J Gersh; C J Coggin; W O Myers
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

Review 4.  Coronary risk factors and the postbypass patient.

Authors:  L Campeau
Journal:  Cardiovasc Clin       Date:  1991

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation.

Authors:  C N Bairey Merz; M N Felando; J Klein
Journal:  J Cardiopulm Rehabil       Date:  1996 Mar-Apr       Impact factor: 2.081

7.  Smoking and myocardial infarction.

Authors:  C Wilhelmsson; J A Vedin; D Elmfeldt; G Tibblin; L Wilhelmsen
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

8.  Stopping smoking and long-term mortality after acute myocardial infarction.

Authors:  J T Salonen
Journal:  Br Heart J       Date:  1980-04

9.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

10.  Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction.

Authors:  L E Daly; R Mulcahy; I M Graham; N Hickey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-30
View more
  3 in total

1.  Interventions to support return to work for people with coronary heart disease.

Authors:  Janice Hegewald; Uta E Wegewitz; Ulrike Euler; Jaap L van Dijk; Jenny Adams; Alba Fishta; Philipp Heinrich; Andreas Seidler
Journal:  Cochrane Database Syst Rev       Date:  2019-03-14

2.  Long-term results of a three-week intensive cardiac out-patient rehabilitation program in motivated patients with low social status.

Authors:  B Bjarnason-Wehrens; D Bott; L Benesch; K O Bischoff; B Buran-Kilian; D Gysan; U Hollenstein; W Mayer-Berger; R Wilkniss; G Sauer
Journal:  Clin Res Cardiol       Date:  2006-12-14       Impact factor: 5.460

Review 3.  [Rehabilitation 2008: when to use outpatient and inpatient rehabilitation?].

Authors:  Gregor Sauer
Journal:  Herz       Date:  2008-09       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.